This study is testing whether a combination of two existing drugs can protect the heart in people with Long COVID who have developed heart inflammation. Researchers will give 279 participants either the active medication or a placebo for 16 weeks to see if it reduces symptoms lik…
Phase: PHASE3 • Sponsor: Valentina Puentmann • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC